Idiopathic neonatal hepatitis (INH) remains a diagnosis of exclusion in the neonate with conjugated hyperbilirubinemia. The major diagnostic challenge for the clinician is to distinguish this condition from other treatable liver disorders such as biliary atresia. Although the prognosis varies for the familial and sporadic forms of neonatal hepatitis, a poor outcome is generally distinguished by chronic and progressive liver failure. After careful review of the literature, we were unable to find a case of INH associated with a profound, irreversible coagulopathy. Herein, we present a case with the primary presenting findings of persistent prolongation of the prothrombin time (PT) and hypofibrinogenemia, resulting in a catastrophic intracranial hemorrhage and death.
chemstrip of Ͻ20 mg/dl was corrected with 15 ml of 5% glucose by gavage and 7 ml of D10W intravenously.
At 3 hours of life, a 20 ml/kg normal saline bolus was administered for hypotension. Her first arterial blood gas, obtained at 4.5 hours of age on an FIO 2 of 0.9 by head hood, revealed a pH of 7.21, a PaCO 2 of 55, a PaO 2 of 212, and a base deficit of Ϫ7. The infant was intubated and placed on mechanical ventilation before transport. Fentanyl and vecuronium were administered. Because of prolonged bleeding following a heel stick, a PT and partial thromboplastin time (PTT) were obtained and found to be 26.3 and 79.6 seconds, respectively. Intravenous fresh frozen plasma was administered as well as boluses of plasmanate followed by dopamine and dobutamine drips to treat the coagulopathy and support systemic blood pressure. A chest X-ray revealed a right pneumothorax that was treated with needle thoracentesis. Ampicillin and gentamicin were also administered.
On admission to the neonatal intensive care unit at 11 hours of age, the infant was placed immediately on high-frequency oscillatory ventilation. Vital signs were as follows: temperature, 100.4°F axillary; pulse, 190 beats per minute; and respirations with the oscillator. Her length was 51 cm and her head circumference was 35.5 cm. The physical examination was remarkable for an intubated and paralyzed newborn with a capillary refill of 2 to 3 seconds. An arterial blood gas demonstrated a pH of 7.23, PaCO 2 of 51, a PaO 2 of 38, and a base deficit of Ϫ6. Her hemoglobin and hematocrit were 10 g% and 29%, respectively, and her platelet count was 123,000/mm 3 . Repeat coagulation studies revealed a PT of 20.9 seconds, a PTT of 69 seconds, and fibrinogen at 59 mg/dl.
The persistent coagulopathy was managed with fresh frozen plasma, platelets, and cryoprecipitate (Table 1) and was felt to be secondary to clinical sepsis and/or perinatal asphyxia. The anemia was successfully treated with packed red blood cell transfusions. Her early hospital course was remarkable for persistent pulmonary hypertension as documented by a right ventricular systolic pressure of 56 mm Hg. This was successfully managed with high-frequency oscillatory ventilation and nitric oxide therapy. Nitric oxide was started at 20 ppm, was decreased to 5 ppm by day of life (DOL) 3, and was discontinued on DOL 7. By DOL 11, she was extubated to low-flow nasal cannula O 2 at 50 ml/minute and was felt to be clinically stable.
The following day she acutely deteriorated and was reintubated for periodic breathing, gasping respirations, and tonic and focal clonic seizures. A coffee-ground gastric aspirate was also noted. Repeat laboratory studies demonstrated a hematocrit of 23%, a platelet count of 143,000/mm 3 , a PT of 24.3 seconds, a PTT of 51 seconds,
and fibrinogen at Ͻ50 mg/dl. A bilirubin was obtained that demonstrated a direct fraction of 8 mg/dl and an indirect fraction of 13 mg/dl. Her anterior fontanelle was firm, and pupils were nonreactive. Treatment consisted of a phenobarbital bolus, cryoprecipitate, fresh frozen plasma, and packed red blood cells. In addition, ticarcillin, tobramycin, vancomycin, and acyclovir were initiated. By the following day (DOL 13) her urine output exceeded 7 ml/kg per hour and her serum sodium was markedly elevated at 159 meq/ liter. A dose of desmopressin acetate was given for presumptive central diabetes insipidus. A computerized tomography scan of the head demonstrated extensive intraventricular and subarachnoid hemorrhages with cerebral edema involving the cerebral and cerebellar cortex consistent with global cerebral infarction. After multiple discussions with family members, life support was discontinued and she died on DOL 15. Postmortem examination of the liver revealed INH with micronodular cirrhosis, intrahepatic cholestasis, and hepatic giant cell formation ( Figure 1, A and B) .
DISCUSSION
To our knowledge, this is the first case report in the literature of INH associated with an early and fatal coagulopathy. Vajro et al. 1 identified cholestasis in 4 of 43 infants with severe asphyxia. A liver biopsy from one of the four infants demonstrated giant cell hepatitis with multinucleated giant cells, hepatocellular swelling, cell necrosis, and intrahepatic cholestasis. Clinical and biochemical signs of liver dysfunction resolved within 1 year in all four patients. The PT was within normal limits for all patients, although there was elevation in some of the liver enzymes.
Our infant did meet the criteria for perinatal asphyxia based on the presence of meconium-stained amniotic fluid, a low 5-minute Apgar score of 3, and the diagnosis of persistent pulmonary hypertension. However, unlike the cases described above, liver histopathology in our patient was free of cellular necrosis and hepatocellular swelling (related to asphyxial liver injury), and the PT was prolonged.
Suita et al. 2 reviewed 32 cases of INH. Five patients died at Յ1 year of age, the youngest being 4 months, secondary to fulminant liver failure, gastrointestinal bleeding, hepatitis, and sudden death. In the 16 cases in which liver histology was examined, increased periportal fibrosis, inflammation, and giant cell transformation were seen in the patients who died. In another series by Deutsch et al. 3 reporting on long-term prognosis, 18 of 73 patients with INH died within the first year of life due to progressive liver failure and septicemia.
The coagulopathy in our patient, manifesting primarily in prolongation of the PT and hypofibrinogenemia, presented at birth and persisted until the time of death despite repeated administration of blood products. The anemia noted on admission was successfully treated with packed red blood cell transfusions. Due to the lack of obvious clinical bleeding, stable hematocrits between DOL 1 and 12, and the infant's steady clinical improvement, coagulation studies were not performed during the 4-day period preceding the catastrophic intracranial hemorrhage. During that time, however, the PT increased from 21.6 to 24.3 and the fibrinogen fell from 105 to Ͻ50.
The interpretation of clotting studies and the diagnosis of hemostatic disorders must be made in the context of age-dependent physiological ranges. Reference values for the PT on DOL 1 in the healthy fullterm newborn range from 10.1 to 15.9 seconds; PTT values range from 31.3 to 54.5 seconds, and fibrinogen values range from 167 to 399 mg/dl. 4 In this case report, the PT remained prolonged despite administration of vitamin K to the infant. In addition, numerous cryoprecipitate transfusions were required to maintain normal fibrinogen levels.
These findings (prolonged PT and persistent hypofibrinogenemia) are most consistent with liver failure secondary to INH. The biphasic clinical course in this infant can be explained by the initial insult of perinatal asphyxia superimposed on and exacerbating the manifestations of congenital liver disease. Although the persistent pulmonary hypertension was successfully treated and the infant was felt to be clinically improving, the coagulopathy persisted, leading ultimately to a fatal hemorrhagic event.
In summary, we conclude that the findings and atypical clinical course in this patient are best explained by the combined effects of two separate disease processes, INH and perinatal asphyxia. Had this been a case of neonatal cholestasis secondary solely to perinatal asphyxia, the outcome should have been favorable. Although asphyxia may also result in cholestasis and a transient coagulopathy secondary to disseminated intravascular coagulation, it is usually self-limited and responds to specific blood component therapy. Conversely, if this represented a case of isolated INH, the outcome should also have been favorable (as reported in 70% to 80% of sporadic cases). Moreover, even in those infants with INH and a poor outcome, death does not occur acutely within the first 2 weeks of life. Indeed, the youngest patient reported was 4 months old. Unfortunately, it appears that in our infant, the combination of perinatal asphyxia and INH led to early and fulminant liver failure manifested by cholestasis, a persistent coagulopathy, catastrophic intracranial hemorrhage, and death.
